皮肤变化超越牛皮:生物疗法对血管瘤和太阳晶状体的影响
Florin Ciprian Bujoreanu1,2,3, Diana Sabina Radaschin1,2,3, Ana Fulga2
1Department of Dermatology, "Saint Parascheva" Infectious Disease Clinical Hospital, 800179 Galati, Romania.
Medicina (Kaunas, Lithuania)
|April 26, 2025
概括
牛皮的生物疗法,特别是IL-23抑制剂,可能会增加桃血管瘤和太阳光. 甲索和UVB治疗显示出对这些皮肤病变的保护作用.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 牛皮是一种慢性炎症性皮肤疾病,用向细胞因子通路的生物药物治疗.
- 这些治疗方法对诸如桃血管瘤和太阳虫等非疹性皮肤病变的影响尚不清楚.
- 桃动脉瘤是血管增殖,而太阳光晶状体是紫外线引起的色素变化.
研究的目的:
- 调查生物疗法的影响,桃血管瘤和太阳光在患有牛皮的患者的发展.
- 探索特定生物病原体,全身炎症和这些皮肤病变的流行之间的关联.
- 识别影响病变发展的潜在保护性或风险因素.
主要方法:
- 在三级皮肤病学中心进行了五年 (2019-2024) 的回顾性观察研究.
- 收集的数据包括临床和人口统计信息,治疗史和数字皮肤镜评估.
- 进行了统计分析,以评估生物治疗类,炎症和病变发展之间的关联.
主要成果:
- 在绝经后妇女,骨质疏松症患者和牛皮关节炎患者中,注意到桃血管瘤患病率增加.
- 与TNF-α抑制剂相比,IL-23抑制剂与更高的血管瘤形成有关;甲醇和UVB治疗显示出保护作用.
- 在更年期后的女性和患有全身炎症的女性中,太阳能晶状体较为常见,TNF-α抑制剂和NSAID与患病率增加有关.
结论:
- 生物疗法,特别是IL-23抑制剂,可能会促进银病患者的血管生成和色素变化.
- 系统性炎症在血管和黑色细胞活动中起作用,影响病变的发展.
- 需要进一步的研究,以了解机制,并优化皮肤病护理,考虑到各种治疗的差异性影响.
相关概念视频
Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
Skin Cancer
2.9K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
2.9K
Tumor Immunotherapy
401
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
401
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K


